Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy.
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy. J Immunother Cancer. 2021 10; 9(10).
View in:
PubMed
subject areas
Animals
Antineoplastic Agents, Immunological
B7-H1 Antigen
Cetuximab
ErbB Receptors
Female
Glycosylation
Head and Neck Neoplasms
Humans
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Mice, Nude
Programmed Cell Death 1 Ligand 2 Protein
Sequence Analysis, RNA
Single-Cell Analysis
Tumor Escape
authors with profiles
Min Li